secwatch.observer — SEC 8-K summary
======================================

Issuer:     eFFECTOR Therapeutics, Inc. (—)
CIK:        0001828522
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0000950170-24-056912
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

eFFECTOR Therapeutics enters $50M ATM equity facility with H.C. Wainwright; terminates prior Cantor agreement
--------------------------------------------------------------------------------

- New ATM offering agreement allows sale of up to $50M in common stock via H.C. Wainwright; agent commission 3.0%.
- Prior ATM agreement with Cantor Fitzgerald terminated; company had sold 1.075M shares for $9.8M under that program.
- Sales under new agreement are at-the-market on Nasdaq; no obligation to sell any shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828522/000095017024056912/0000950170-24-056912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828522/000095017024056912/eftr-20240509.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-056912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer